Hans Fliri
Impact in
- Ophthalmology top 5%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
- Pharmacology top 10%
- Cannabis and Cannabinoid Research
Papers in
-
- Synthesis of β-Lactam Compounds 8
- Cyclopropane Reaction Mechanisms 3
- Synthesis and Catalytic Reactions 3
- Synthesis and Biological Evaluation 2
-
- Signaling Pathways in Disease 2
- Co-authors
- Clive L. Cornell (5 shared papers)David F. Woodward (4 shared papers)Simon N. Pettit (4 shared papers)Jose L. Martos (4 shared papers)Yuanbo Liang (2 shared papers)Robert W. Carling (2 shared papers)Michael E. Garst (2 shared papers)W. Daniel Stamer (2 shared papers)
- Journals
- The Journal of Organic Chemistry (3 papers)Investigative Ophthalmology & Visual Science (2 papers)Tetrahedron Letters (2 papers)Nature Communications (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- AustriaUnited StatesIreland
In The Last Decade
Hans Fliri
19 papers receiving 476 citations
Peers
Comparison fields: 5 of 71
- Ophthalmology 125
- Pharmacology 119
- Toxicology 14
- Biochemistry 28
- Organic Chemistry 80
Countries citing papers authored by Hans Fliri
This map shows the geographic impact of Hans Fliri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Fliri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Fliri more than expected).
Fields of papers citing papers by Hans Fliri
This network shows the impact of papers produced by Hans Fliri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Fliri. The network helps show where Hans Fliri may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Fliri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 106 | |
| 2 | 2008 | 79 | |
| 3 | 2008 | 78 | |
| 4 | 2007 | 70 | |
| 5 | 1985 | 37 | |
| 6 | 2010 | 35 | |
| 7 | 1993 | 29 | |
| 8 | 1982 | 11 | |
| 9 | 1977 | 10 | |
| 10 | 1983 | 8 | |
| 11 | 1978 | 8 | |
| 12 | 1983 | 5 | |
| 13 | 1987 | 3 | |
| 14 | 1982 | 3 | |
| 15 | 1979 | 2 | |
| 16 | Prolyl Isomerases -Old Proteins as New Therapeutic Targets | 2015 | 2 |
| 17 | 2023 | 1 | |
| 18 | 1987 | 1 | |
| 19 | 1985 | 1 |
About Hans Fliri
Hans Fliri is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Ophthalmology and Pathology and Forensic Medicine, having authored 19 papers that have together received 489 indexed citations. Recurring topics across this work include Synthesis of β-Lactam Compounds (8 papers), Cyclopropane Reaction Mechanisms (3 papers), Synthesis and Catalytic Reactions (3 papers), Signaling Pathways in Disease (2 papers), Glaucoma and retinal disorders (2 papers), Synthesis and Biological Evaluation (2 papers), Chemical Reactions and Mechanisms (1 paper) and Pneumocystis jirovecii pneumonia detection and treatment (1 paper). The work is most often cited by research in Ophthalmology (125 citations), Pharmacology (119 citations), Toxicology (14 citations), Biochemistry (28 citations) and Organic Chemistry (80 citations). Hans Fliri has collaborated with scholars based in Austria, United States and Ireland. Frequent co-authors include Clive L. Cornell, David F. Woodward, Simon N. Pettit, Jose L. Martos, Yuanbo Liang, Robert W. Carling, Michael E. Garst, W. Daniel Stamer, Jenny W. Wang and Ching‐Pong Mak. Their work appears in journals such as The Journal of Organic Chemistry, Investigative Ophthalmology & Visual Science, Tetrahedron Letters, Nature Communications and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.